Journal of Immunology Research

Cell-mediated Immunity and Vaccines


Publishing date
31 Mar 2014
Status
Published
Submission deadline
11 Nov 2013

Lead Editor

1Norwegian College of Fishery Science, Faculty of Biosciences, Fisheries and Economics, University of Tromso, 9037Tromso, Norway

2Division of cell biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA

3School of Biological Sciences, National Institute of Science Education and Research (NISER), Bhubaneswar, Orissa751005, India


Cell-mediated Immunity and Vaccines

Description

Cell-mediated immunity (CMI) is a critical component during immunological responses to infectious diseases, cancer, and autoimmunity. Research into immunological correlates of protection has exposed limitations of vaccine approaches that rely mostly on antibody responses to confer immunity against pathogens. These limits underscore the need for representative biomarkers and establishment of immune monitoring parameters for novel vaccines aiming to elicit cellular immunity.

The main focus of this special issue will be (i) the functional network of protective cellular responses against infection, tumor, and autoimmune conditions, (ii) the approaches used to induce CMI-mediated protection, and (iii) the characterization of the critical parameters useful in optimizing vaccine design and development. This special issue will be an international forum for researchers to summarize recent developments and ideas in the field of cellular immunology, with emphasis on the observational results obtained. Potential topics include, but are not limited to:

  • Development of cell-mediated immunity vaccines as an efficient alternative and/or synergistic approach to antibody-based vaccines for viral infections (identification of biomarkers/correlates of cell-mediated immunity after infection, efficacy assessment of cell-mediated immunity vaccination)
  • The challenges of immune evasion and immunoprivileged sites in vaccine development
  • Mucosal immunity and vaccines
  • Role of regulatory T cells in vaccination or the effector/regulatory T-cell balance in vaccine development
  • T-cell-based vaccines against chronic (persistent) virus infection and immune exhaustion
  • NK cell interactions with monocytes-macrophages, DC, and T, B, and NKT lymphocytes and their implications in the immunity against viral infections, malignancy, and autoimmunity
  • Immunometabolism and vaccines
  • Antitumor cell-mediated immunity and vaccination strategies
  • Vaccination and CD4 T-cell responses
  • Exploitation of cross-presentation and autoimmune response in vaccine development
  • Selection of effective adjuvants in cell-mediated immune vaccination against pathogenic microorganisms, tumors, and/or autoimmunity
  • New approaches to enhance regulatory cell-mediated immunity in autoimmune conditions and cell-mediated vaccine approach to autoimmune diseases

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/jir/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/jir/cmiv/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 632632
  • - Editorial

Cell-Mediated Immunity and Vaccines

Jaya Kumari | Senthamil R. Selvan | ... | Roy Ambli Dalmo
  • Special Issue
  • - Volume 2014
  • - Article ID 897214
  • - Review Article

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors

Clara E. Jäkel | Annabelle Vogt | ... | Ingo G. H. Schmidt-Wolf
  • Special Issue
  • - Volume 2013
  • - Article ID 283649
  • - Research Article

Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100

Kai Naumann | Rebekka Wehner | ... | Jacques Rohayem
  • Special Issue
  • - Volume 2013
  • - Article ID 271246
  • - Research Article

Combinations of TLR Ligands: A Promising Approach in Cancer Immunotherapy

Saskia Stier | Claudia Maletzki | ... | Michael Linnebacher
  • Special Issue
  • - Volume 2013
  • - Article ID 132432
  • - Research Article

Haemophilus parasuis Subunit Vaccines Based on Native Proteins with Affinity to Porcine Transferrin Prevent the Expression of Proinflammatory Chemokines and Cytokines in Pigs

R. Frandoloso | S. Martínez-Martínez | ... | C. B. Gutiérrez-Martín
  • Special Issue
  • - Volume 2013
  • - Article ID 686919
  • - Research Article

CD8 Knockout Mice Are Protected from Challenge by Vaccination with WR201, a Live Attenuated Mutant of Brucella melitensis

Samuel L. Yingst | Mina Izadjoo | David L. Hoover
Journal of Immunology Research
 Journal metrics
Acceptance rate40%
Submission to final decision64 days
Acceptance to publication30 days
CiteScore3.330
Impact Factor3.404
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.